Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Cerny

Showing results (91-100 of 144) with videos related to

Pageof 15
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1991
Phase II studies of 4'-iodo-4'-deoxydoxorubicin in advanced non-small cell lung, colon and breast cancersC Sessa, F Calabresi, F Cavalli, et al.
Seminars in Oncology|November 28, 1997
Dose-finding study of paclitaxel and cyclophosphamide in women with advanced breast cancerC Sessa, O Pagani, G Martinelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1997
Dose-finding study of paclitaxel and cyclophosphamide in advanced breast cancerO Pagani, C Sessa, G Martinelli, et al.
Leukemia & Lymphoma|March 1, 1995
Patterns of drug resistance parameters in adult leukemiaF Joncourt, A E Oberli-Schrämmli, M Stadler, et al.
Cancer Research|April 15, 1991
Assessment of P-glycoprotein, glutathione-based detoxifying enzymes and O6-alkylguanine-DNA alkyltransferase as potential indicators of constitutive drug resistance in human colorectal tumorsS M Redmond, F Joncourt, K Buser, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1991
Continuous 5-day infusion of ifosfamide with mesna in inoperable pancreatic cancer patients: a phase II studyT Cerny, G Martinelli, A Goldhirsch, et al.
Cancer Research|October 18, 2000
Prostate stem cell antigen is a promising candidate for immunotherapy of advanced prostate cancerJ Dannull, P A Diener, L Prikler, et al.
Lancet (London, England)|November 27, 1993
Cladribine and severe myelotoxicityD C Betticher, M F Fey, M Rabaglio, et al.
Cancer|November 15, 1987
Ifosfamide, etoposide, and thoracic irradiation therapy in 163 patients with unresectable small cell lung cancerN Thatcher, T Cerny, R Stout, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 1997
Phase II trial of the oral platinum complex JM216 in non-small-cell lung cancer: an EORTC early clinical studies group investigationI Judson, T Cerny, R Epelbaum, et al.
Pageof 15

Showing results (91-100 of 144) with videos related to

Sort By:
Pageof 15
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1991
Phase II studies of 4'-iodo-4'-deoxydoxorubicin in advanced non-small cell lung, colon and breast cancersC Sessa, F Calabresi, F Cavalli, et al.
Seminars in Oncology|November 28, 1997
Dose-finding study of paclitaxel and cyclophosphamide in women with advanced breast cancerC Sessa, O Pagani, G Martinelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1997
Dose-finding study of paclitaxel and cyclophosphamide in advanced breast cancerO Pagani, C Sessa, G Martinelli, et al.
Leukemia & Lymphoma|March 1, 1995
Patterns of drug resistance parameters in adult leukemiaF Joncourt, A E Oberli-Schrämmli, M Stadler, et al.
Cancer Research|April 15, 1991
Assessment of P-glycoprotein, glutathione-based detoxifying enzymes and O6-alkylguanine-DNA alkyltransferase as potential indicators of constitutive drug resistance in human colorectal tumorsS M Redmond, F Joncourt, K Buser, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1991
Continuous 5-day infusion of ifosfamide with mesna in inoperable pancreatic cancer patients: a phase II studyT Cerny, G Martinelli, A Goldhirsch, et al.
Cancer Research|October 18, 2000
Prostate stem cell antigen is a promising candidate for immunotherapy of advanced prostate cancerJ Dannull, P A Diener, L Prikler, et al.
Lancet (London, England)|November 27, 1993
Cladribine and severe myelotoxicityD C Betticher, M F Fey, M Rabaglio, et al.
Cancer|November 15, 1987
Ifosfamide, etoposide, and thoracic irradiation therapy in 163 patients with unresectable small cell lung cancerN Thatcher, T Cerny, R Stout, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 1997
Phase II trial of the oral platinum complex JM216 in non-small-cell lung cancer: an EORTC early clinical studies group investigationI Judson, T Cerny, R Epelbaum, et al.
Pageof 15